secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pacira BioSciences, Inc. (PCRX)
CIK:        0001396814
Form:       8-K
Filed at:   2024-08-09T23:59:59+00:00
Accession:  0001396814-24-000103
Event type: litigation
Sentiment:  negative
Materiality: 0.85
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pacira's EXPAREL patent invalidated by New Jersey court; company plans appeal
-----------------------------------------------------------------------------

- U.S. District Court for D.N.J. ruled Pacira's U.S. Patent No. 11,033,495 for EXPAREL is invalid.
- Company intends to appeal the decision to the U.S. Court of Appeals for the Federal Circuit.
- Three separate infringement suits against eVenus remain ongoing; additional patents pending.
- CEO Frank D. Lee stated belief in patent strength and that EXPAREL franchise is well protected.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1396814/000139681424000103/0001396814-24-000103-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1396814/000139681424000103/pcrx-20240809.htm
  HTML page:      https://secwatch.observer/filing/0001396814-24-000103

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer